Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.
INTRODUCTION: The overall survival rate is good for lymph-node-negative breast cancer patients, but they still suffer from serious over- and some undertreatments. Prognostic and predictive gene signatures for node-negative breast cancer have a high number of genes related to proliferation. The progn...
Main Authors: | Kristin Jonsdottir, Jörg Assmus, Aida Slewa, Einar Gudlaugsson, Ivar Skaland, Jan P A Baak, Emiel A M Janssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3944091?pdf=render |
Similar Items
-
Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
by: Kristin Jonsdottir, et al.
Published: (2012-01-01) -
Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.
by: Nina Gran Egeland, et al.
Published: (2019-01-01) -
Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting prognosis of non-muscle invasive papillary urothelial carcinomas
by: Vebjørn Kvikstad, et al.
Published: (2024-01-01) -
MiR-18a and miR-18b are expressed in the stroma of oestrogen receptor alpha negative breast cancers
by: Nina Gran Egeland, et al.
Published: (2020-05-01) -
The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
by: Marie Klintman, et al.
Published: (2013-01-01)